Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.
Center of Healthy Aging, University of Copenhagen, Copenhagen, Denmark.
Invest Ophthalmol Vis Sci. 2019 Mar 1;60(4):999-1008. doi: 10.1167/iovs.18-25458.
Besides being actively metabolized, lactate may also function as a signaling molecule by activation of the G-protein-coupled receptor 81 (GPR81). Thus, we aimed to characterize the metabolic effects of GPR81 activation in Müller cells.
Primary Müller cells from mice were treated with and without 10 mM L-lactate in the presence or absence of 6 mM glucose. The effects of lactate receptor GPR81 activation were evaluated by the addition of 5 mM 3,5-DHBA (3,5-dihydroxybenzoic acid), a GPR81 agonist. Western blot analyses were used to determine protein expression of GPR81. Cell survival was assessed through 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) viability assays. Lactate release was quantified by commercially available lactate kits. 13C-labeling studies via mass spectroscopy and Seahorse analyses were performed to evaluate metabolism of lactate and glucose, and mitochondrial function. Finally, Müller cell function was evaluated by measuring glutamate uptake.
The lactate receptor, GPR81, was upregulated during glucose deprivation. Treatment with a GPR81 agonist did not affect Müller cell survival. However, GPR81 activation diminished lactate release allowing lactate to be metabolized intracellularly. Furthermore, GPR81 activation increased metabolism of glucose and mitochondrial function. Finally, maximal glutamate uptake decreased in response to GPR81 activation during glucose deprivation.
The present study revealed dual properties of lactate via functioning as an active metabolic energy substrate and a regulatory molecule by activation of the GPR81 receptor in primary Müller cells. Thus, combinational therapy of lactate and GPR81 agonists may be of future interest in maintaining Müller cell survival, ultimately leading to increased resistance toward retinal neurodegeneration.
除了被主动代谢外,乳酸还可以通过激活 G 蛋白偶联受体 81(GPR81)作为信号分子发挥作用。因此,我们旨在研究 GPR81 激活对 Müller 细胞代谢的影响。
用 10 mM L-乳酸处理来自小鼠的原代 Müller 细胞,并在有或没有 6 mM 葡萄糖的情况下,用或不用 5 mM 3,5-DHBA(3,5-二羟基苯甲酸)处理,3,5-DHBA 是 GPR81 的激动剂。通过 Western blot 分析来确定 GPR81 受体的蛋白表达。通过 3-(4,5-二甲基-2-噻唑基)-2,5-二苯基-2H-四唑溴盐(MTT)活力测定法评估细胞存活率。通过商业可得的乳酸试剂盒定量测定乳酸释放。通过质谱和 Seahorse 分析进行 13C 标记研究,以评估乳酸和葡萄糖的代谢和线粒体功能。最后,通过测量谷氨酸摄取来评估 Müller 细胞功能。
在葡萄糖剥夺期间,乳酸受体 GPR81 上调。GPR81 激动剂的处理不影响 Müller 细胞的存活率。然而,GPR81 激活减少了乳酸的释放,使乳酸能够在细胞内被代谢。此外,GPR81 激活增加了葡萄糖代谢和线粒体功能。最后,在葡萄糖剥夺期间,GPR81 激活导致最大谷氨酸摄取减少。
本研究揭示了 GPR81 在原代 Müller 细胞中激活时,乳酸通过作为活性代谢能量底物和调节分子的双重特性。因此,乳酸和 GPR81 激动剂的联合治疗可能对维持 Müller 细胞的存活具有未来意义,最终导致对视网膜神经退行性变的抵抗力增强。